(0.10%) 5 527.25 points
(0.20%) 39 546 points
(0.05%) 19 937 points
(0.38%) $81.85
(-1.04%) $2.57
(-0.19%) $2 335.20
(0.95%) $29.52
(-1.02%) $1 003.80
(-0.48%) $0.929
(-0.47%) $10.63
(-0.19%) $0.789
(1.49%) $87.00
Live Chart Being Loaded With Signals
OptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits...
Stats | |
---|---|
本日の出来高 | 126 115 |
平均出来高 | 150 758 |
時価総額 | 15.65M |
EPS | £-0.00210 ( Q4 | 2023-12-31 ) |
次の収益日 | ( £0 ) 2024-09-25 |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E |
-7.70 (Sector) 0 (Industry) 0 |
ATR14 | £0.306 (1.99%) |
OptiBiotix Health PLC 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
OptiBiotix Health PLC 財務諸表
Annual | 2023 |
収益: | £644 000 |
総利益: | £320 000 (49.69 %) |
EPS: | £-0.0226 |
FY | 2023 |
収益: | £644 000 |
総利益: | £320 000 (49.69 %) |
EPS: | £-0.0226 |
FY | 2022 |
収益: | £457 000 |
総利益: | £244 000 (53.39 %) |
EPS: | £0.0293 |
FY | 2021 |
収益: | £2.21M |
総利益: | £1.12M (50.76 %) |
EPS: | £0.0718 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
OptiBiotix Health PLC
OptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; WellBiome, a functional fibre and mineral blend that supports health & wellbeing by promoting the diversity of the gut microbiome; and Sweetbiotix, a sweetener for use in food and beverages. The company's products prevents and manages chronic lifestyle diseases, including obesity, hypercholesterolemia and lipid profiles, and diabetes. OptiBiotix Health Plc was founded in 2012 and is headquartered in York, the United Kingdom.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。